121 related articles for article (PubMed ID: 26458553)
1. Additive effects of eukaryotic co‑expression plasmid carrying GRIM‑19 and LKB1 genes on breast cancer in vitro and in vivo.
Zhang W; Shao Y; Du Y; Geng W; Jiang T; Liu H; Zhang D
Mol Med Rep; 2015 Nov; 12(5):7665-72. PubMed ID: 26458553
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor effect of cisplatin in human oral squamous cell carcinoma cells by tumor suppressor GRIM‑19.
Li M; Li Z; Li J; Jin L; Jin C; Han C; Ji X; Sun F
Mol Med Rep; 2015 Dec; 12(6):8185-92. PubMed ID: 26458285
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of eukaryotic coexpression plasmid carrying LKB1 and FUS1 genes on lung cancer in vitro and in vivo.
Li L; Yu C; Ren J; Ye S; Ou W; Wang Y; Yang W; Zhong G; Chen X; Shi H; Su X; Chen L; Zhu W
J Cancer Res Clin Oncol; 2014 Jun; 140(6):895-907. PubMed ID: 24659339
[TBL] [Abstract][Full Text] [Related]
5. Plasmid-based Stat3-specific siRNA and GRIM-19 inhibit the growth of thyroid cancer cells in vitro and in vivo.
Wang GM; Ren ZX; Wang PS; Su C; Zhang WX; Liu ZG; Zhang L; Zhao XJ; Chen G
Oncol Rep; 2014 Aug; 32(2):573-80. PubMed ID: 24899100
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.
Pan Y; Zhang L; Zhang X; Liu R
Oncol Rep; 2015 Feb; 33(2):774-82. PubMed ID: 25420630
[TBL] [Abstract][Full Text] [Related]
7. Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.
Li F; Qi J; Qin C; Fu Z; Ren W
Oncol Rep; 2018 Dec; 40(6):3743-3751. PubMed ID: 30272302
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of GRIM-19 inhibits the growth and invasion of human breast cancer cells.
Zhang W; Du Y; Jiang T; Geng W; Yuan J; Zhang D
Mol Med Rep; 2015 Aug; 12(2):2919-25. PubMed ID: 25955394
[TBL] [Abstract][Full Text] [Related]
9. Construction of recombinant adenovirus carrying GRIM19 and its effect on SW480 cells.
Wang S; Wang G; Deng Y; Luo X; Li X; Tao D; Gong J; Hu J
J Huazhong Univ Sci Technolog Med Sci; 2008 Feb; 28(1):14-6. PubMed ID: 18278448
[TBL] [Abstract][Full Text] [Related]
10. [Effects of WWOX gene transfection on cell growth of epithelial ovarian cancer].
Yan HC; Xue JQ; Lu XY; Wan MR; Feng X; Liu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):361-5. PubMed ID: 18953870
[TBL] [Abstract][Full Text] [Related]
11. Effects of plasmid-based Stat3-specific short hairpin RNA and GRIM-19 on PC-3M tumor cell growth.
Zhang L; Gao L; Li Y; Lin G; Shao Y; Ji K; Yu H; Hu J; Kalvakolanu DV; Kopecko DJ; Zhao X; Xu DQ
Clin Cancer Res; 2008 Jan; 14(2):559-68. PubMed ID: 18223232
[TBL] [Abstract][Full Text] [Related]
12. Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells.
Jain P; Baranwal S; Dong S; Struckhoff AP; Worthylake RA; Alahari SK
J Biol Chem; 2013 May; 288(22):15495-509. PubMed ID: 23572524
[TBL] [Abstract][Full Text] [Related]
13. Nonviral Delivery of
Xu Y; Wang X; Guo B; Wang D; Kalvakolanu DV; Chen X; Tang J; Zhang L; Yang Q
Hum Gene Ther; 2019 Nov; 30(11):1419-1430. PubMed ID: 31382833
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of LKB1 in breast cancer cells attenuates angiogenesis, invasion, and metastatic potential.
Zhuang ZG; Di GH; Shen ZZ; Ding J; Shao ZM
Mol Cancer Res; 2006 Nov; 4(11):843-9. PubMed ID: 17114342
[TBL] [Abstract][Full Text] [Related]
15. LKB1 promotes radioresistance in esophageal cancer cells exposed to radiation, by suppression of apoptosis and activation of autophagy via the AMPK pathway.
He Q; Li J; Dong F; Cai C; Zou X
Mol Med Rep; 2017 Aug; 16(2):2205-2210. PubMed ID: 28656285
[TBL] [Abstract][Full Text] [Related]
16. Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.
Sengupta S; Nagalingam A; Muniraj N; Bonner MY; Mistriotis P; Afthinos A; Kuppusamy P; Lanoue D; Cho S; Korangath P; Shriver M; Begum A; Merino VF; Huang CY; Arbiser JL; Matsui W; Győrffy B; Konstantopoulos K; Sukumar S; Marignani PA; Saxena NK; Sharma D
Oncogene; 2017 Oct; 36(41):5709-5721. PubMed ID: 28581518
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of GRIM-19 suppresses the growth of oral squamous cell carcinoma in vitro and in vivo.
Li M; Li Z; Liang C; Han C; Huang W; Sun F
Oncol Rep; 2014 Nov; 32(5):2183-90. PubMed ID: 25174621
[TBL] [Abstract][Full Text] [Related]
18. Enhanced antitumor effect of cisplatin in human NSCLC cells by tumor suppressor LKB1.
Ou W; Ye S; Yang W; Wang Y; Ma Q; Yu C; Shi H; Yuan Z; Zhong G; Ren J; Zhu W; Wei Y
Cancer Gene Ther; 2012 Jul; 19(7):489-98. PubMed ID: 22576699
[TBL] [Abstract][Full Text] [Related]
19. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
20. [Function and prognostic value of tumor suppressor gene LKB1 in human breast carcinoma].
Shen Z; Wu Q; Yue L; Li HC; Shen ZZ; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):15-8. PubMed ID: 15808068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
